Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of “palateau”

The first-line therapy of metastatic renal cell carcinoma (mRCC) has revolutionized with the approval of immune checkpoint inhibitors (ICIs) in combination with or without tyrosine kinase inhibitors (TKIs). The choice among the many different immuno-combinations (ICI-ICI or ICI-TKI) is challenging d...

全面介紹

書目詳細資料

Principais autores:	Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Pasquale Rescigno, Giuseppe Luigi Banna, Sebastiano Buti
格式:	Artigo
語言:	Inglês
出版:	Taylor & Francis Group 2024-12-01
叢編:	Human Vaccines & Immunotherapeutics
主題:	Renal cell carcinoma immune checkpoint inhibitor immuno-combination immunotherapy survival outcomes
在線閱讀:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2351669
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!